Ngm Biopharmaceuticals Inc Asset Turnover Ratio (NGM), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ngm Biopharmaceuticals Inc   (NASDAQ: NGM)
 

Ngm Biopharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Ngm Biopharmaceuticals Inc 's asset turnover ratio, the ratio that measures the ability of Ngm Biopharmaceuticals Inc 's assets to generate revenue, sequentially decreased to 0.02 in the fourth quarter (Dec 31 2023), which does not come as a surprise, as the Ngm Biopharmaceuticals Inc continue to experience difficult business climate.

Within sector 66 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2023, to 1651, from total ranking in the third quarter 2023 at 1846.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NGM Asset Turnover Ratio (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Asset Change -45.12 % -42.51 % -34.74 % -27.96 % -24.6 %
Y / Y Revenue Change -99.09 % -92.64 % -82.84 % -89.27 % -13.25 %
Asset Turnover Ratio (TTM) 0.02 0.09 0.11 0.12 0.17
NGM's Total Ranking # 1651 # 1846 # 611 # 2249 # 1935
Seq. Asset Change -12.53 % -12.76 % -14.94 % -15.45 % -8.36 %
Seq. Revenue Change -71.65 % -59.1 % -36.67 % -87.64 % 129.82 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 67
Healthcare Sector # 159
Overall Market # 1651

Asset Turnover Ratio Statistics
High Average Low
1049.47 138.49 7.37
(Dec 31 2020)   (Mar 31 2023)




NGM Company Profile • Back to NGM Efficiency Comparisons • Compare NGM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Soligenix inc   0.07 $ 0.839  Millions$ 11.507  Millions
Dbv Technologies S a   0.07 $ 15.728  Millions$ 218.656  Millions
Hcw Biologics Inc   0.07 $ 2.560  Millions$ 36.787  Millions
Avalo Therapeutics Inc   0.07 $ 1.924  Millions$ 27.683  Millions
Recursion Pharmaceuticals Inc   0.07 $ 44.575  Millions$ 644.647  Millions
Curevac N v   0.07 $ 60.209  Millions$ 882.839  Millions
Arvinas Inc   0.07 $ 78.500  Millions$ 1,155.550  Millions
Lexaria Bioscience Corp   0.07 $ 0.276  Millions$ 4.066  Millions
Immuron Limited  0.07 $ 1.480  Millions$ 21.988  Millions
Arch Therapeutics Inc   0.07 $ 0.115  Millions$ 1.734  Millions
Verrica Pharmaceuticals Inc   0.07 $ 5.124  Millions$ 77.396  Millions
Vaxart Inc   0.07 $ 7.379  Millions$ 112.494  Millions
Northwest Biotherapeutics Inc  0.06 $ 1.932  Millions$ 30.167  Millions
4d Molecular Therapeutics Inc   0.06 $ 20.723  Millions$ 324.507  Millions
Lucid Diagnostics Inc   0.06 $ 2.428  Millions$ 38.031  Millions
Quantum Cyber N v   0.06 $ 1.146  Millions$ 18.040  Millions
Co diagnostics Inc   0.06 $ 6.812  Millions$ 108.450  Millions
Solana Company  0.06 $ 0.644  Millions$ 10.264  Millions
Pavmed Inc   0.06 $ 2.957  Millions$ 48.527  Millions
Femasys Inc   0.06 $ 1.072  Millions$ 17.698  Millions
Delcath Systems Inc   0.06 $ 2.065  Millions$ 34.460  Millions
Syros Pharmaceuticals Inc   0.06 $ 9.936  Millions$ 175.569  Millions
C4 Therapeutics Inc   0.06 $ 20.756  Millions$ 370.127  Millions
Mountain Crest Acquisition Corp V  0.06 $ 0.511  Millions$ 9.260  Millions
Galapagos Nv  0.06 $ 268.491  Millions$ 4,880.284  Millions
60 Degrees Pharmaceuticals Inc   0.05 $ 0.254  Millions$ 4.776  Millions
Xtl Biopharmaceuticals Ltd   0.05 $ 0.451  Millions$ 8.550  Millions
Onemednet Corporation  0.05 $ 1.040  Millions$ 19.878  Millions
Bicycle Therapeutics Plc  0.05 $ 26.976  Millions$ 529.250  Millions
Imagenebio Inc   0.05 $ 9.160  Millions$ 182.898  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.